Latigo Biotherapeutics (LTGO) vs Mentari Therapeutics (MTRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Latigo Biotherapeutics is the larger company by market cap ($861.9 million vs $856.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LTGO | MTRI |
|---|---|---|
| Share price | $13.00 | $14.70 |
| Market cap | $861.89M | $856.94M |
| 1-day change | -1.81% | -3.57% |
| EPS (TTM) | $-6.07 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.93 | $23.30 |
| 52-week low | $10.24 | $5.75 |
| Distance from 52-week high | -49.87% | -36.91% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +301.92% | — |
| Average volume | 309.60K | 19.42K |
| Shares outstanding | 66.30M | 58.30M |
| Employees | 66 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Latigo Biotherapeutics
LTGO stock →Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.
Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees
About Mentari Therapeutics
MTRI stock →Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways.
Health Care · Biotechnology: Pharmaceutical Preparations
LTGO vs MTRI FAQ
Which is bigger, Latigo Biotherapeutics or Mentari Therapeutics?
Latigo Biotherapeutics (LTGO) is larger, with a market capitalization of $861.89M compared with $856.94M for Mentari Therapeutics (MTRI).
Are Latigo Biotherapeutics and Mentari Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.